Skip to main content
. 2022 Oct 3;108(2):397–404. doi: 10.1210/clinem/dgac563

Figure 2.

Figure 2.

Cumulative hazard of recurrence (A) and only metastatic disease (B) among patients with sporadic vs hereditary PPGL. Patients with cluster 1 PPGL presented with a 2.45-fold higher risk of recurrence compared with those with sporadic tumors, whereas risk of recurrence was similar between patients with cluster 2 and sporadic PPGL (A). Similarly, patients with cluster 1 PPGL presented with a 2.48-fold higher risk of metastasis compared with those with sporadic tumors, whereas risk of recurrence was similar between patients with cluster 2 and sporadic PPGL (B).